- Home
- XERS vs GBX Comparison
XERS vs GBX Comparison
Compare XERS & GBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XERS | GBX |
|---|---|---|
| Founded | 2005 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Railroads |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | XERS | GBX |
|---|---|---|
| Price | $6.72 | $46.51 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 7 | 3 |
| Target Price | $10.00 | ★ $50.67 |
| AVG Volume (30 Days) | ★ 2.8M | 259.2K |
| Earning Date | 11-06-2025 | 01-07-2026 |
| Dividend Yield | N/A | ★ 2.74% |
| EPS Growth | N/A | ★ 27.96 |
| EPS | N/A | ★ 6.35 |
| Revenue | $266,137,000.00 | ★ $3,240,200,000.00 |
| Revenue This Year | $43.89 | N/A |
| Revenue Next Year | $20.40 | N/A |
| P/E Ratio | ★ N/A | $7.35 |
| Revenue Growth | ★ 42.05 | N/A |
| 52 Week Low | $3.14 | $37.77 |
| 52 Week High | $10.08 | $71.06 |
Technical Indicators
Market Signals| Indicator | XERS | GBX |
|---|---|---|
| Relative Strength Index (RSI) | 34.93 | 69.32 |
| Support Level | $6.47 | $44.36 |
| Resistance Level | $7.24 | $45.13 |
| Average True Range (ATR) | 0.29 | 1.11 |
| MACD | -0.02 | 0.51 |
| Stochastic Oscillator | 24.81 | 89.64 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About GBX Greenbrier Companies Inc. (The)
Greenbrier Companies Inc supplies equipment and services to international freight transportation markets, designing and marketing freight railcars in North America, Europe, and Brazil through subsidiaries and joint ventures. It provides railcar wheel services, parts, maintenance, and conversion services in North America. The company owns a lease fleet sourced mainly from its manufacturing operations and offers railcar management, regulatory compliance, and leasing services to railroads and owners. It operates two segments: Manufacturing and Leasing & Fleet Management, with the majority of revenue from Manufacturing. The company operates in the U.S. and internationally, with the majority of revenue from the U.S. market.